The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kozlovskiĭ V.L.

FGBU "Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva", Sankt-Peterburg

Ronzhina O.S.

Bekhterev Psychoneurological Research Institute, St. Petersburg, Russia

Nosospecific anxiety and a spectrum of anxiolytic activity of psychotropic drugs

Authors:

Kozlovskiĭ V.L., Ronzhina O.S.

More about the authors

Read: 1759 times


To cite this article:

Kozlovskiĭ VL, Ronzhina OS. Nosospecific anxiety and a spectrum of anxiolytic activity of psychotropic drugs. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(4):96‑101. (In Russ.)
https://doi.org/10.17116/jnevro20171174196-101

Recommended articles:
The follow-up examination of children with breath-holding spells. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11-2):76-80
Subjective sleep quality evaluation in patients with neuromyelitis optica spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):57-61
Therapeutic targets of adolescent depression with atte­nuated symptoms of schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):69-74
Impact of various reha­bilitation programs on anxiety and depression after surgery of early-stage cervical cancer. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(5):40-44

References:

  1. Nuller YuL. Trevoga i ee terapiya. Psikhiatriya i psikhofarmakoterapiya im. P.B. Gannushkina. SPb.: Psikhonevrologicheskii institut im. V.M. Bekhtereva. 2002. (In Russ.).
  2. Sel'e G. Na urovne tselogo organizma. M.: Nauka; 1972. (In Russ.).
  3. Tsigos C, Chrousos GP. Hypothalamic — pituitary — adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002;53(4):865-871.
  4. Kutlu MG, Gould TJ. Nicotine modulation of fear memories and anxiety: Implications for learning and anxiety disorders. Biochemical Pharmacology. 2015;97(4):498-511. doi:10.1016/j.bcp.2015.07.029
  5. Tochilov VA. Ob issledovanii struktury i lechenii affektivnykh pristupov. Obozrenie psikhiatrii i meditsinskoi psikhologii. 1992;(2):28-36. (In Russ.).
  6. Tochilov VA, Shirokov VD. Ispol'zovanie seduksenovogo testa pri issledovanii struktury i vybora terapii trevozhno-depressivnykh sostoyanii. Malye trankvilizatory v lechenii i reabilitatsii bol'nykh psikhonevrologicheskimi i psikhosomaticheskimi zabolevaniyami. L. 1979. (In Russ.).
  7. Rapee RM, Barlow DH. (Eds). Chronic anxiety. New York: The Guilford Pres; 1991.
  8. Nuller YuL. Paradigmy v psikhiatrii. Kiiv: Vidannya Asotsiats ii psikhiatriv Ukraini; 1993. (In Russ.).
  9. Psikhiatriya: natsional'noe rukovodstvo. Pod red. Dmitrievoi T.B., Krasnova V.N., Neznanova N.G., Semke V.Ya., Tiganova A.S., Aleksandrovskogo Yu.A. M.: Izdatel'stvo GEOTAR-Media; 2014. (In Russ.).
  10. Lapin IP. Anksiogeny v modelyakh dlya otbora i issledovaniya protivotrevozhnykh preparatov. Nauchno-metodologicheskie aspekty biologicheskikh issledovanii novykh lekarstvennykh preparatov. Riga: Zinatne; 1987. (In Russ.).
  11. File SE, Kenny PJ, Cheeta S. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol Biochem Behav. 2000;66(1):65-72.
  12. Kutlu MG, Gould TJ. Nicotine modulation of fear memories and anxiety: Implications for learning and anxiety disorders. Biochem Pharmacol. 2015;97(4):498-511. doi:10.1016/j.bcp.2015.07.029
  13. Sher L. The role of the endogenous opioid system in the pathogenesis of anxiety disorders. Medical Hypotheses. 1998;50:473-474.
  14. Handley R, Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ‘fear’-motivated behavior. Naunyn-Schmiedebergs Arch Pharmacol. 1984;327(1):105; 23.
  15. Simon P, Panissaud C, Costentin J. Anxiogenic-like effects induced by stimulation of dopamine receptorst. Pharmacol Biochem Behav. 1993;45(3):685-690.
  16. Gafford GM, Ressler KJ. GABA and NMDA receptors in CRF neurons have opposing effects in fear acquisition and anxiety in central amygdala vs. bed nucleus of the stria terminalis. Horm Behav. 2015;76:136-142. doi:10.1016/j.yhbeh.2015.04.001
  17. Stahl SM. Essential Psychopharmacology. Neuroscientific basis and practical application. New York: Cambridge Universisty Press; 2013.
  18. Shin LM, Liberzon I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology. 2010;35(1):169-191. doi:10.1038/npp.2009.83
  19. David DJ, Gardier AM. The pharmacological basis of the serotonin system: Application to antidepressant response. Encephale. 2016;42(3):255-63. doi:10.1016/j.encep.2016.03.012
  20. Sundstrom-Poromaa I, Smith DH, Gong QH, Sabado TN, Li X, Light A, Wiedmann M, Williams K, Smith SS. Hormonally regulated alpha(4)beta(2)delta GABA(A) receptors are a target for alcohol. Nat Neurosci. 2002;5(8):721-722. doi:10.1038/nn888
  21. Ticku MK. Alcohol and GABA-benzodiazepine receptor function. Ann Med. 1990;22(4):241-246.
  22. Ticku MK. Ethanol and the benzodiazepine — GABA receptor — ionophore complex. Experientia. 1989;45(5):413-418.
  23. Gilpin NW, Herman MA, Roberto M. The Central Amygdala as an Integrative Hub for Anxiety and Alcohol Use Disorders. Biol Psychiatry. 2015;77(10):859-869. doi:10.1016/j.biopsych.2014.09.008
  24. Orlikov A.B. O klinicheskoi tipologii trevozhnykh sostoyanii. Obozrenie psikhiatrii i meditsinskoi psikhologii im. V.M. Bekhtereva. 1992;1:57-64.
  25. Klinicheskie razbory v psikhiatricheskoi praktike. Pod red. Gofmana A.G. M.: Izdatel'stvo MEDpress-inform; 2006.
  26. Simon P, Panissaud C, Costentin J. Sulpiride anxiogenic-like effect inhibition by a D1 dopamine receptor antagonist. Neuroreport. 1992;3(10):941-942.
  27. Popov MYu. Trevoga v strukture ostrykh psikhoticheskikh sostoyanii kak obosnovanie podkhodov k terapii. Psikhiatriya i psikhofarmakoterapiya. 2002;4(2): 54. (In Russ.).
  28. Nuller YuL, Mikhalenko IN. Affektivnye psikhozy. L.: Meditsina; 1988. (In Russ.).
  29. Limanskii YuP. Morfofunktsional'naya organizatsiya aminergicheskikh sistem i ikh rol' v motornoi deyatel'nosti mozga. Uspekhi fiziologicheskikh nauk. 1990;21(2):3-17. (In Russ.).
  30. Shatsberg AF, Cole DO, DeBattista Ch. The Manual of clinical psychopharmacology. M.: Medpress-inform; 2014. (In Russ.).
  31. Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C, Alsobrook J, Peterson BS, Cohen DJ, Rasmussen SA, Goodman WK, McDougle CJ, Pauls DL. Symptoms of obsessive-compulsive disorder. Am J Psychiatry. 1997;154(7):911-917. doi:10.1176/ajp.154.7.911
  32. Psikhiatriya: natsional'noe rukovodstvo. Pod red. Dmitrievoi T.B., Krasnova V.N., Neznanova N.G., Semke V.Ya., Tiganova A.S., Aleksandrovskogo Yu.A. M.: Izdatel'stvo GEOTAR-Media; 2014. (In Russ.).
  33. Zwanzger P. Pharmacotherapy of Anxiety Disorders. Fortschr Neurol Psychiatr. 2016;84(5):306-314. doi:10.1055/s-0042-106764
  34. Kozlovskii VL. Pochemu protivoepilepticheskie preparaty yavlyayutsya timostabilizatorami (psikhofarmakologiya protivoepilepticheskikh sredstv). Sotsial'naya i klinicheskaya psikhiatriya. 2015;25(4):72-78. (In Russ.).
  35. Curran C, Byrappa N, McBride A. Stimulant psychosis: systematic review. The British Journal of Psychiatry. 2004;185:196-204. doi:10.1192/bjp.185.3.196
  36. Enna SJ. Role of gamma-aminobutyric acid in anxiety. Psychopharmacology. 1984;17(suppl 1):15-24.
  37. Celentano JJ, Gibbs TT, Farb DH. Ethanol potentiates GABA- and glycine-induced chloride currents in chick spinal cord neurons. Brain Res. 1988;455:377-380.
  38. Michaelis E, Roy S, Galton N, Cunningham M, Lecluyse E, Michaelis M. Correlation of glutamate binding activity with glutamate-binding protein immunoreactivity in the brain of control and alcohol-treated rats. Neurochem Int. 1987;11(2):209-218.
  39. Kushner MG, Abrams K, Borchardt C. The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clin Psychol Rev. 2000;20(2):149-171.
  40. Pedrelli P, Shapero B, Archibald A, Dale C. Alcohol use and depression during adolescence and young adulthood: a summary and interpretation of mixed findings. Curr Addict Rep. 2016;3(1):91-97. doi:10.1007/s40429-016-0084-0

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.